ERBB2 and breast cancer: We also demonstrated that presence of CHD1L over-expression was associated with younger age, higher tumor grade, HER2 over-expression/amplification, and higher Ki-67 labeling index, which are all prognostic factors of unfavorable breast cancer biology.